Cryoport, Inc. SEC filings CYRX
Cryoport, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 15, 2008. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Jun 5, 2026 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 6, 2025 |
| DEFA14A | Additional proxy material | Apr 3, 2024 | — |
| DEF 14A | Proxy statement | Apr 3, 2024 | May 17, 2024 |
| DEFA14A | Additional proxy material | Mar 31, 2023 | — |
| DEF 14A | Proxy statement | Mar 31, 2023 | — |
| DEFA14A | Additional proxy material | Mar 18, 2022 | — |
| DEF 14A | Proxy statement | Mar 18, 2022 | Apr 29, 2022 |
| DEFA14A | Additional proxy material | Apr 21, 2021 | — |
| DEFA14A | Additional proxy material | Mar 16, 2021 | — |
| DEF 14A | Proxy statement | Mar 16, 2021 | Apr 30, 2021 |
| DEF 14A | Proxy statement | Apr 3, 2020 | May 1, 2020 |
| DEF 14A | Proxy statement | Apr 3, 2019 | May 2, 2019 |
| DEF 14A | Proxy statement | Apr 9, 2018 | May 17, 2018 |
| PRE 14A | Preliminary proxy statement | Mar 30, 2018 | Mar 30, 2018 |
| DEF 14A | Proxy statement | Aug 11, 2017 | Sep 12, 2017 |
| DEF 14A | Proxy statement | Sep 2, 2016 | Sep 21, 2016 |
| PRE 14A | Preliminary proxy statement | Aug 11, 2016 | Aug 11, 2016 |
| DEFA14A | Additional proxy material | Oct 23, 2015 | — |
| DEF 14A | Proxy statement | Oct 1, 2015 | Oct 28, 2015 |
| PRE 14A | Preliminary proxy statement | Sep 21, 2015 | Sep 18, 2015 |
| DEF 14A | Proxy statement | Jul 25, 2014 | Aug 29, 2014 |
| DEF 14A | Proxy statement | Jul 29, 2013 | Sep 6, 2013 |
| DEF 14A | Proxy statement | Jul 30, 2012 | Sep 13, 2012 |
| DEF 14A | Proxy statement | Aug 15, 2011 | Sep 22, 2011 |
| PRE 14A | Preliminary proxy statement | Aug 3, 2011 | Sep 22, 2011 |
| DEF 14A | Proxy statement | Jul 22, 2010 | Aug 31, 2010 |
| PRE 14A | Preliminary proxy statement | Jul 12, 2010 | Aug 31, 2010 |
| DEF 14A | Proxy statement | Sep 11, 2009 | Oct 9, 2009 |
| PRE 14A | Preliminary proxy statement | Sep 1, 2009 | Oct 9, 2009 |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CYRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Brentwood, TN
- SEC filer status
- Accelerated filer
- SEC CIK
- 1124524
- Former names
- CRYOPORT SYSTEMS INC (until Oct 20, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.